作者
Daniel R Rosen, Teepu Siddique, David Patterson, Denise A Figlewicz, Peter Sapp, Afif Hentati, Deirdre Donaldson, Jun Goto, Jeremiah P O'Regan, Han-Xiang Deng, Zohra Rahmani, Aldis Krizus, Diane McKenna-Yasek, Annarueber Cayabyab, Sandra M Gaston, Ralph Berger, Rudolph E Tanzi, John J Halperin, Brian Herzfeldt, Raymond Van den Bergh, Wu-Yen Hung, Thomas Bird, Gang Deng, Donald W Mulder, Celestine Smyth, Nigel G Laing, Edwin Soriano, Margaret A Pericak–Vance, Jonathan Haines, Guy A Rouleau, James S Gusella, H Robert Horvitz, Robert H Brown Jr
发表日期
1993/3/4
期刊
Nature
卷号
362
期号
6415
页码范围
59-62
出版商
Nature Publishing Group UK
简介
AMYOTROPHIC lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord1,2. Its cause is unknown and it is uniformly fatal, typically within five years3. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade4,5. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar4,6,7. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8,9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2 to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders11, we …
引用总数
1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202465188194227187197191201179209213222229264278298289320381386353354343335370340313360381369273151